The treatment of malignant glial tumours remains a tremendous challenge despite decades of pre-clinical and clinical research. These tumours represent about 80% of all primary brain tumours, and have a universally unfavourable prognosis despite new radiotherapy protocols and chemotherapy regimens.
highly variable, ranging from 50% to 100%. 4, 10, 11 A considerable variation in tumour volumes can also be observed within a group of implanted animals using the same technique. A recently published study reported tumour volumes ranging from less than 10 mm 3 to more than 80 mm 3 after a standardized implantation technique and a constant observation period. 12 This thus illustrates the difficulty in interpreting response to an experimental treatment based only on the tumour size at pathology after euthanasia of the animal.
In order to minimize the impact of these variations and decrease several sources of bias that could produce false positive results, in vivo tumour assessment is mandatory in the use of these models. Magnetic resonance has become the standard imaging technology in the follow-up of brain tumours in the clinical situation. In an effort to emulate the clinical context and to validate and monitor glioma implantation models, it is thus only natural to extend the use of this imaging modality to the laboratory. Using small and powerful magnets up to 7 Tesla and custom made antennas, high resolution imaging was obtained from different groups. [13] [14] [15] [16] This MR technology has been used to assess brain tumour formation 11 and volumes, 13, 14 tumour vascularisation, 15 blood-brain barrier permeability 17, 18 and responses to various therapeutic agents. 14, 19 This equipment leads to very good quality imaging but is not widespread in use and is not easily available. When reviewing current literature on the subject, a trend seems to emerge in that the high field magnet technology gradually becomes a standard in animal imaging. 11, 14 While this technology is doubtlessly useful, most notably for all the physiological data acquisitions, we believe that it is not mandatory for tumour follow-up assessments focusing on the size of tumour and response to treatment. Although we do not have access to high field magnet technology, we are nonetheless active in the field of neuro-oncology research.
The objectives of this study were threefold: 1) to define optimal parameters allowing imaging of the F98 Fisher glioma model with a commercially available antenna, using the 1.5T Siemens magnet MR scan available at our university center 2) to assess the accuracy of this approach in following in vivo tumour progression in the F98-Fischer model and 3) to ensure that the imaging findings match the corresponding pathology samples.
METHODS

Animal model
The experimental protocol was approved by the institutional ethical committee and conformed to regulations of the Canadian Council on animal care. Thirteen adult male Fischer rats were obtained and kept in controlled conditions in our facilities.
The F98 cell line (ATCC), was grown in monolayer using a solution of Dulbecco's modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum and a mix of penicillin-streptomycin. Cells were incubated at 37°C in a humidified environment with 5% CO 2 and propagated upon confluence, every three days. The implantation solution was prepared by trypsinization of the cell culture followed by resuspension in a DMEM solution free of fetal bovine serum. The solution was diluted to obtain a concentration of 1x10 4 cells in a volume of five microliters. A trypan blue exclusion test was performed to assess cell viability before implantation.
The implantation procedures were performed under general anesthesia using an intraperitoneal injection of ketamine (87mg/kg) and xylazine (13mg/kg). A midline incision on the scalp was accomplished to expose the bregma. . After a delay of one minute, the needle was slowly withdrawn and the burr hole sealed with bone wax. The scalp was closed using a running suture. The animals were allowed to awake and were observed for a variable period.
Experimental groups
One animal was used for a series of test images to define the optimal imaging parameters. After acquiring this data, each of the 12 remaining animals was randomly assigned to one of the four experimental groups corresponding to the interval between the implantation procedure and the MRI. To permit corresponding pathological study, the animals were sacrificed immediately after the MRI. The groups were divided as follows: five, ten, 15 and 20 days.
Imaging
The test animal was anesthetized with ketamine/xylazine (as previously described for the implantation procedure) and taken to the MR suite. After a series of preliminary images, the Siemens small loop flex coil (4 cm diameter) was chosen as the ideal antenna. It was simply laid on the head of the rat and secured with tape ( Figure 1 ). The animal was positioned inside the magnet in prone position. Images were acquired in the coronal plane. The TR and TE were varied in a series of serial test imaging until images were considered optimal, both for the 
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T1 and the T2 sequences. This implies that, once a certain point had been reached, further manipulations did not improve image quality or definition, but increased acquisition time. For T1 weighted images, the final parameters used were a TR of 400, and a TE of 17 whereas for T2 weighted images, a TR of 3340, and a TE of 99 were selected. The matrix specified was 512 x 384. Slice thickness was 2 mm and six slices per specimen were obtained. We also performed enhanced T1 weighted images with IV Gadopentetate dimeglumine. The contrast agent was injected via the penile vein (0.1 cc of a 469 mg/cc solution). The acquisition time was seven minutes for T2 and five minutes for T1 images. Using these parameters, images deemed adequate were produced in T2, T1 and T1 with gadolinium.
Pathology
After the MRI procedure, while still under general anesthesia, rats were euthanized by means of intracardiac formaldehyde perfusion. The brains were harvested and preserved in formalin solution. The specimens were then sliced in coronal sections using a brain matrix and sent to the pathology laboratory for hematoxylin and eosin staining.
Image processing
Histological slides depicting the largest tumour area on pathology were selected for each animal, digitized and compared with the corresponding MR image. Both images were analyzed using the image processing software "SigmaScan Pro 5" (Hallogram Publishing, Aurora, USA). The tumour contour was manually drawn for the pathology slides, whereas the enhancement signal on T1 was drawn for the MR images. The software calculated area measurements in mm 2 after conversion and standardization from pixel units (Figure 2) .
RESULTS
Tumour was observed in each animal and produced a bright and homogeneous enhancement. Enhanced T1 images were used to calculate tumour surface, as there was a clear demarcation between enhancing tumour and surrounding brain. Analysis of enhancing signal on MRI produced the following surface measurements: 2.18 mm 2 ± 0.91 at five days, 8.25 mm 2 ± 0.91 at ten days, 21.6 mm 2 ± 2.38 at 15 days and 23.17 mm 2 ± 2.56 at 20 days. The T2 images allowed a clear recognition of anatomical structures, such as the ventricules and basal ganglia. It also depicted the mass effect and shift in the midline caused by the tumour. The interface between tumour and normal brain was blurred, without a clear margin on the T2 sequences.
Tumour margin evaluation on pathologic samples generated surfaces of 0.29 mm 2 ± 0.2 at five days, 4.43 mm 2 ± 0.89 at ten days, 8.3 mm 2 ± 0.22 at 15 days and 12.9 mm 2 ± 0.45 at 20 days. For all the animals assessed, a good match between radiology and pathology regarding the topographic distribution of the tumours was found (Figure 3) . However, although a parallel increase in tumour areas was noted on both the histological sample and the MR scan for every animal, a significant discrepancy was obvious, with the MR surfaces significantly greater than the histological surfaces. This overestimation was present in every subject in a constant fashion. As can be appreciated from the data, the histology samples depicted a consistency in the calculated areas, whereas the MR data was more variable.
DISCUSSION
A multiplicity of rat glioma models have been described in the literature. Each of these models displays different characteristics rendering them unique. We elected to work with the F98/Fischer model because it regroups some of the characteristics which we think are essentials in the establishment of a valid glioma model. 20 The F98 cell line was developed at Ohio State University by a single dose of ENU administered to a pregnant Fischer rat. 21 This model is characterized by an infiltrative growth pattern and histopathological morphology matching that of an anaplastic glioma. 22 It is also very weakly immunogenic when used with its syngeneic host, the Fischer rat. 23 In improving the validity of data acquired through these experimental models, in vivo assessment modalities are essential to monitor responses of experimental treatment strategies and to allow radiological follow-up of the animals. 12 The F98 model has already been studied with MRI, but only using experimental high field magnets. 24, 25 Other glioma models have been studied using regular magnet with commercially available antenna. 11 However, these studies are scarce, and most recently published works focus on the use of either high-field experimental magnets, and/or custom made antennas. [13] [14] [15] [16] While there is no denying that these technologies are worthwhile and useful, they are expensive and are not readily available to most laboratories. 11 Moreover, even though these high field magnet units can be used to gain greater insight in the physiology and the biological behaviour of a tumour and its surrounding (Blood brain barrier (BBB) integrity, brain around tumour vascularisation and so on), they might not be necessary to study tumour progression and response to various treatment strategies. 11 To do so, we believe that a human MR with a commercial antenna can lend images of adequate resolution.
In this study, adequate T1 sequences were obtained for the entire population of animals imaged, enabling successful tumour surface quantification using T1 enhanced sequences. We used a small coil antenna that was simply laid on the head of the animal, thus maximizing signal strength. Although we also tested images in axial and sagittal sequences, only the coronal plane was later routinely imaged, given that no additional data was gained with the other planes. The surface measurements obtained showed a gradual increase with time to implantation, as was expected (Figure 3 ). However we found an overlap of standard deviations in this set of data. The small sample size, and the short interval time between each group imaged likely contribute to this phenomenon. Comparing tumour surfaces using longer interval times would have led to statistically significant results.
The present study was also designed to assess the relationship in tumour morphology and topography between the pathology sample and T1-enhancing images obtained in corresponding animal. Ultimately, we intended to ensure the validity of this imaging technique in following in vivo tumour growth.
As expected, tumour areas as measured by MR imaging showed a gradual increase in time, which parallels the pathological findings. However, when looking at the data, we found a constant overestimation of tumour size with MR imaging. Many factors could explain this discrepancy. It is a well known fact that tissue fixation and processing with formalin and paraffin cause shrinkage due to dehydration. The shrinkage factor reported is highly variable, ranging from 7% to 33% in the literature. 26, 27 This variation is probably explained by differences in the fixation techniques. Different methods have been described to measure the shrinkage factor. 28 To establish this factor in the present study, we elected to measure the entire brain surfaces on MR imagery and on the corresponding pathological slides in three randomly selected rats. The images were analyzed using the image processing software as described in the methods section. Corresponding images were manually contoured for brain area calculation, expressed as pixel units. These surface calculations were averaged, and a ratio pathology sample/ MRI of 0.84 was calculated. The shrinking factor was thus estimated at 16%. When this correction factor was applied to the results, the correspondence between the two modalities was improved (Figure 4) . Even though the shrinking factor explains some of the difference evidenced between the pathology sample and the MR image, other mechanisms are active in producing this discrepancy.
One such factor is the phenomenon of neovascularisation at the brain around tumour area. The F98 tumours produced by our implantation technique are characterized by an endothelial proliferation that extends beyond the tumour nodule into a zone of adjacent brain infiltration, the so-called brain around tumour area ( Figure 5 ). This phenomenon is tributary to the invasive behavior of the F98 cells, and emulates the human situation of a malignant astrocytoma. 29 These new capillaries lack tight junctions, which render them permeable to macromolecules. This altered permeability is the basis of enhanced imaging, but can lead to overestimation of tumour size, because the enhancing signal might include the brain around tumour area.
Tumour proliferation in the subdural compartment is yet another mechanism contributing to the discrepancy between the pathology samples and corresponding imaging by MR. In certain imaging samples, it appears that tumour cells proliferated into the subdural space ( Figure 6 ). This phenomenon has been described in countless reports, and is related to the implantation process. More specifically, the leptomeningeal puncture and the needle tract produced by the implantation technique are physical anomalies through which the tumour cells can backtrack and produce subdural tumour growth. Despite our efforts to eradicate this problem by using a small infusion volume, slowly retracting the needle and sealing the craniotomy with bone wax, we still occasionally encounter significant extra-axial tumour growth. When analyzing the MR images, it is impossible to accurately separate this growth from the main tumour nodule. However, when harvesting the brain, this extra-axial growth is inevitably removed with the dura. Thus, the MR surface calculation results include this artifact which is absent from the pathological surface calculations ( Figure 6 ).
As animal models are increasingly used to assess in vivo efficacy of different therapies, a need to devise in vivo imaging strategies in these models has emerged. Numerous models are in use, and significant variation in the tumour take, growth pattern and survival time of the animals are reported. This study reports our findings in assessing radiologically F98-implanted Fischer rats with a commercial magnet and antenna, using a standardized implantation technique. Although the MR scans consistently overestimated the actual tumour size, the radiological tumour growth reported in this study paralleled the histological samples. This technology is thus suitable to follow in vivo tumour growth of animals exposed to a standardized implantation technique in which a treatment modality needs to be assessed, keeping in mind the limitations imposed by this overestimation. 
